进博会观察|中国市场需求驱动创新 跨国公司押注本土化

Core Insights - The Chinese market is increasingly attractive for multinational companies due to its unique characteristics, strong industrial clusters, and efficient innovation centers [1] Group 1: Local Value Chain Development - The conditions and prospects for foreign investment in China are improving, with the 2024 Global Foreign Direct Investment Confidence Index ranking China 3rd, up from 7th in 2023 [2] - Asahi Kasei showcased sustainable innovations at the China International Import Expo, emphasizing collaboration and co-creation with the Chinese market [2] - Asahi Kasei plans to implement a "technology landing + joint innovation" model to enhance local partnerships and address market needs [2] Group 2: Localized R&D and Manufacturing - Nippon Paint expanded its exhibition space at the expo and introduced several innovative solutions aligned with national development priorities [3][4] - Nippon Paint has over 70 production bases and 10 R&D centers in China, with significant investments in local manufacturing capabilities [3][4] - Boston Scientific has accelerated local integration in R&D and manufacturing, launching multiple locally developed medical devices [5] Group 3: Strategic Investments and Collaborations - Medtronic announced its first localized TAVR surgical AI solution and established a digital medical innovation base in Beijing [6][7] - Cargill has signed over $30 billion in cooperation agreements at the expo, focusing on animal nutrition and health solutions [7][8] - Cargill is investing in upgrading its Shanghai innovation center and expanding its production facilities in China [8]